In its investor presentation, Laurus Labs said that they are well on track to deliver healthy operational growth for financial year 2026.
The final trading day of the week promises to be full of action with regards to quarterly results, with over 50 companies ...
India, Jan. 23 -- This mid-cap Pharma stock, engaged in developing and manufacturing APIs, formulations, and biotech products ...